Hendrik Vilstrup

Hendrik Vilstrup's AcademicInfluence.com Rankings

Hendrik Vilstrup

Biology

#8844

World Rank

#11978

Historical Rank

Biotechnology

#112

World Rank

#114

Historical Rank

Genetics

#891

World Rank

#987

Historical Rank

Molecular Biology

#1151

World Rank

#1177

Historical Rank

biology Degrees

Download Badge

Biology

Hendrik Vilstrup's Degrees

PhD Biomedical Sciences University of Copenhagen
Masters Biotechnology Technical University of Denmark
Bachelors Biotechnology Technical University of Denmark

Why Is Hendrik Vilstrup Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Hendrik Vilstrup's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver (2014) (1268)
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis (2018) (419)
Risk of Venous Thromboembolism in Patients With Liver Disease: A Nationwide Population-Based Case–Control Study (2009) (412)
Clinical course of alcoholic liver cirrhosis: A Danish population‐based cohort study (2010) (408)
The nutritional management of hepatic encephalopathy in patients with cirrhosis: International society for hepatic encephalopathy and nitrogen metabolism consensus (2013) (307)
Risk of liver and other types of cancer in patients with cirrhosis: A nationwide cohort study in Denmark (1998) (297)
Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). (2014) (248)
Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. (2014) (240)
Branched-chain amino acids for people with hepatic encephalopathy. (2017) (191)
Portal vein thrombosis; risk factors, clinical presentation and treatment (2007) (185)
Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus (2017) (163)
Strict insulin therapy normalises organ nitrogen contents and the capacity of urea nitrogen synthesis in experimental diabetes in rats (1988) (157)
Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study. (2003) (153)
Acute Pain Induces Insulin Resistance in Humans (2001) (150)
Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C (2014) (147)
Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices. (2001) (140)
Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites (2016) (139)
Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark. (2003) (135)
Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology. (2011) (130)
The clinical course of cirrhosis: The importance of multistate models and competing risks analysis (2015) (128)
Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis (2012) (124)
High Volume Plasma Exchange in Fulminant Hepatic Failure (1992) (123)
Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. (2020) (122)
Incidence and mortality of alcoholic hepatitis in Denmark 1999-2008: a nationwide population based cohort study. (2011) (121)
Synthesis of urea after stimulation with amino acids: relation to liver function. (1980) (120)
Comorbidity and survival of Danish cirrhosis patients: A nationwide population‐based cohort study (2008) (119)
Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity (2011) (118)
Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS (2011) (111)
Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging (2011) (110)
Decreased muscle strength in patients with alcoholic liver cirrhosis in relation to nutritional status, alcohol abstinence, liver function, and neuropathy (1998) (107)
Brain metabolism of 13N‐ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography (2006) (103)
Acetaminophen use during pregnancy: effects on risk for congenital abnormalities. (2008) (103)
Risk of Cancer in Patients Hospitalized With Fatty Liver: A Danish Cohort Study (2003) (102)
Urea cycle dysregulation in non-alcoholic fatty liver disease. (2018) (101)
Low cerebral oxygen consumption and blood flow in patients with cirrhosis and an acute episode of hepatic encephalopathy. (2009) (99)
Development and validation of a comorbidity scoring system for patients with cirrhosis. (2014) (99)
Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials. (2013) (98)
Nonselective β‐blockers do not affect mortality in cirrhosis patients with ascites: Post Hoc analysis of three randomized controlled trials with 1198 patients (2015) (97)
A nationwide study of the incidence and 30‐day mortality rate of pyogenic liver abscess in Denmark, 1977–2002 (2005) (95)
Risk for Hepatocellular Carcinoma in Patients With Alcoholic Cirrhosis (2012) (95)
Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002. (2007) (92)
Crosstalk between adipose tissue insulin resistance and liver macrophages in Non Alcoholic Fatty Liver Disease. (2019) (92)
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. (2016) (89)
Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF). (2016) (88)
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non‐alcoholic fatty liver disease (2016) (87)
Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence? (2013) (87)
Risk of Breast Cancer in Men With Liver Cirrhosis (1998) (85)
Data Quality of Administratively Collected Hospital Discharge Data for Liver Cirrhosis Epidemiology (1997) (85)
Cerebral effects of ammonia in liver disease: current hypotheses (2014) (82)
Glucoregulation in acute liver failure (1986) (82)
Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta‐analysis (2016) (79)
Hepatic Macrophage Activation and the LPS Pathway in Patients With Alcoholic Hepatitis: A Prospective Cohort Study (2014) (79)
Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis. (2018) (78)
Liver cirrhosis, other liver diseases, and risk of hospitalisation for intracerebral haemorrhage: A Danish population-based case-control study (2008) (75)
The liver-alpha cell axis and type 2 diabetes. (2019) (72)
Glucagon increases hepatic efficacy for urea synthesis. (1990) (71)
L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis. (2018) (70)
Hepatic encephalopathy is associated with decreased cerebral oxygen metabolism and blood flow, not increased ammonia uptake (2013) (70)
Branched-chain amino acids and muscle ammonia detoxification in cirrhosis (2013) (70)
Worldwide Incidence of Autoimmune Liver Disease (2015) (69)
Alcoholic cirrhosis in Denmark – population-based incidence, prevalence, and hospitalization rates between 1988 and 2005: A descriptive cohort study (2008) (68)
Effect of a 10-week Weight Loss Camp on Fatty Liver Disease and Insulin Sensitivity in Obese Danish Children (2012) (68)
Alcohol consumption and serum liver-derived enzymes in a Danish population aged 30-50 years. (1997) (67)
The continuous reaction times method for diagnosing, grading, and monitoring minimal/covert hepatic encephalopathy (2013) (66)
Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy. A comparative study of 154 patients with liver disease (2011) (66)
Cirrhosis patients have increased risk of complications after hip or knee arthroplasty (2015) (64)
Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects. (2004) (64)
Kinetics of glucose metabolism in relation to insulin concentrations in patients with alcoholic cirrhosis and in healthy persons. (1984) (62)
Cirrhosis and mortality risks of biopsy‐verified alcoholic pure steatosis and steatohepatitis: a nationwide registry‐based study (2012) (61)
The Prevalence of Wilson’s Disease: An Update (2020) (60)
Increased urinary excretion of aquaporin 2 in patients with liver cirrhosis (2003) (60)
Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis. (1990) (60)
Incidence rates of hepatocellular carcinoma in the U.S. and Denmark: Recent trends (2007) (58)
Cirrhosis and bacterial infections. (2003) (58)
On urea synthesis--regulation in vivo. (1989) (56)
Diabetes as a risk factor for hepatic encephalopathy in cirrhosis patients. (2015) (56)
The metabolic role of isoleucine in detoxification of ammonia in cultured mouse neurons and astrocytes (2007) (55)
Cerebral blood flow autoregulation is absent in rats with thioacetamide-induced hepatic failure. (1994) (55)
Incidence and prognosis of cholangiocarcinoma in Danish patients with and without inflammatory bowel disease: a national cohort study, 1978–2003 (2009) (54)
Cancer risk in persons receiving prescriptions for paracetamol: A Danish cohort study (2002) (54)
Increased risk and case fatality rate of pyogenic liver abscess in patients with liver cirrhosis: a nationwide study in Denmark (2001) (54)
Plasma clearances of branched-chain amino acids in control subjects and in patients with cirrhosis. (1987) (53)
Validation of prognostic scores for clinical use in patients with alcoholic hepatitis (2011) (53)
Macrophage activation marker soluble CD163 and non‐alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery (2015) (52)
Contribution of defects in glucose uptake to carbohydrate intolerance in liver cirrhosis: assessment during physiological glucose and insulin concentrations. (2005) (52)
The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children (2015) (50)
Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes (2016) (47)
Branched-chain amino acids increase arterial blood ammonia in spite of enhanced intrinsic muscle ammonia metabolism in patients with cirrhosis and healthy subjects. (2011) (47)
Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease. (2014) (46)
Glucagon Immunoneutralization in Diabetic Rats Normalizes Urea Synthesis and Decreases Nitrogen Wasting (1992) (46)
Increased intestinal hydrolysis of urea in patients with alcoholic cirrhosis. (1985) (46)
Effects of streptozotocin-induced diabetes and diet on nitrogen loss from organs and on the capacity of urea synthesis in rats (1987) (45)
Plasma cystatin C as a marker of renal function in patients with liver cirrhosis (2002) (45)
Short-term and long-term causes of death in patients with alcoholic hepatitis in Denmark. (2014) (45)
Acute pain induces an instant increase in natural killer cell cytotoxicity in humans and this response is abolished by local anaesthesia. (1999) (45)
Intrahepatic Heterogeneity of Hepatic Venous Pressure Gradient in Human Cirrhosis (2002) (45)
Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis (2020) (45)
A method for determination of the capacity of urea synthesis in the rat. (1985) (45)
Quantitative liver functions in Turner syndrome with and without hormone replacement therapy. (2007) (45)
Experimental nonalcoholic steatohepatitis compromises ureagenesis, an essential hepatic metabolic function. (2014) (44)
Effects of growth hormone and insulin‐like growth factor‐I singly and in combination on in vivo capacity of urea synthesis, gene expression of urea cycle enzymes, and organ nitrogen contents in rats (1997) (44)
Resistance Training Increases Muscle Strength and Muscle Size in Patients With Liver Cirrhosis. (2020) (43)
Time dependent stimulating effect of glucagon on the capacity of urea-N synthesis in rats. (1987) (43)
Effects of an increase in protein intake on hepatic efficacy for urea synthesis in healthy subjects and in patients with cirrhosis. (1992) (41)
Detoxification of Ammonia in Mouse Cortical GABAergic Cell Cultures Increases Neuronal Oxidative Metabolism and Reveals an Emerging Role for Release of Glucose-Derived Alanine (2011) (41)
Hepatic macrophage activation predicts clinical decompensation in chronic liver disease (2013) (40)
Non‐alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion (2019) (40)
Synthesis of neurotransmitter GABA via the neuronal tricarboxylic acid cycle is elevated in rats with liver cirrhosis consistent with a high GABAergic tone in chronic hepatic encephalopathy (2011) (39)
Elimination of infused amino acids from plasma of control subjects and of patients with cirrhosis of the liver (1982) (39)
Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes (2008) (39)
Intrahepatic Heterogeneity of Hepatic Venous Pressure Gradient in Human Cirrhosis Again (2002) (38)
Importance of flow and haematocrit for metabolic function of perfused rat liver. (1980) (38)
Inhibition of glutamine synthesis induces glutamate dehydrogenase-dependent ammonia fixation into alanine in co-cultures of astrocytes and neurons (2011) (37)
Brain Alanine Formation as an Ammonia-Scavenging Pathway during Hyperammonemia: Effects of Glutamine Synthetase Inhibition in Rats and Astrocyte—Neuron Co-Cultures (2013) (37)
Human insulin release processes measured by intraportal sampling. (2002) (37)
Cirrhosis is Associated with an Increased 30-Day Mortality After Venous Thromboembolism (2015) (37)
Increased amino acid clearance and urea synthesis in a patient with glucagonoma. (1990) (36)
Muscle strength, Na,K‐pumps, magnesium and potassium in patients with alcoholic liver cirrhosis – relation to spironolactone (2002) (36)
Discrimination between organic and hepatic encephalopathy by means of continuous reaction times. (2008) (35)
Hepatic amino‐nitrogen clearance to urea‐nitrogen in control subjects and in patients with cirrhosis: A simplified method (1991) (35)
Increased hepatic efficacy of urea synthesis from alanine in insulin‐dependent diabetes mellitus (1990) (33)
Impedance Planimetric Characterization of Esophagus in Systemic Sclerosis Patients with Severe Involvement of Esophagus (1997) (33)
Increased hepatic amino nitrogen conversion after elective cholecystectomy in man. (1988) (33)
Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease—Current Knowledge, Mechanisms and Perspectives (2021) (32)
Effect of weight reduction on insulin sensitivity, sex hormone-binding globulin, sex hormones and gonadotrophins in obese children. (2010) (32)
The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study (2009) (32)
The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients (2017) (32)
Metabolic fate of isoleucine in a rat model of hepatic encephalopathy and in cultured neural cells exposed to ammonia (2009) (32)
Dexamethasone increases the capacity of urea synthesis time dependently and reduces the body weight of rats. (2008) (32)
Satavaptan treatment for ascites in patients with cirrhosis: a meta-analysis of effect on hepatic encephalopathy development (2013) (32)
The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosis (2016) (32)
Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis (2017) (31)
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. (2016) (31)
Effects of glucose on alanine-derived urea synthesis. (1984) (31)
Highest Frequencies of Interleukin-22-Producing T Helper Cells in Alcoholic Hepatitis Patients with a Favourable Short-Term Course (2013) (31)
Pregnancy and birth outcomes in a Danish nationwide cohort of women with autoimmune hepatitis and matched population controls (2018) (31)
Insulin and glucose decreases the capacity of urea-N synthesis in the rat. (1986) (30)
Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis (2012) (30)
Physical exercise for people with cirrhosis. (2018) (30)
Growth hormone prevents prednisolone-induced increase in functional hepatic nitrogen clearance in normal man. (1997) (29)
Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by AASLD and EASL (2014) (29)
Single‐centre experience of the macrophage activation marker soluble (s)CD163 – associations with disease activity and treatment response in patients with autoimmune hepatitis (2016) (29)
Passage of amino acids and glucose across the blood‐brain barrier in patients with hepatic encephalopathy (1993) (29)
Body composition changes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis. (2010) (29)
Ammonia: A novel target for the treatment of non-alcoholic steatohepatitis. (2018) (29)
Loss of nitrogen from organs in rats induced by exogenous glucagon. (1988) (29)
Prognosis of patients with liver cirrhosis and spontaneous bacterial peritonitis. (2003) (28)
Effects of insulin and glucose on urea synthesis in normal man, independent of pancreatic hormone secretion. (1994) (28)
Effects of growth hormone on steroid-induced increase in ability of urea synthesis and urea enzyme mRNA levels. (1998) (28)
Regulation of urea synthesis by glucose and glucagon in normal man. (1994) (28)
Fetal Growth and Adverse Birth Outcomes in Women Receiving Prescriptions for Acetaminophen During Pregnancy (1999) (28)
Epidemiology of alcoholic liver disease in Denmark 2006-2011: a population-based study. (2015) (27)
Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma (2016) (27)
Diagnosis of Helicobacter Pylori Infection is Associated with Lower Prevalence and Subsequent Incidence of Crohn's Disease. (2016) (27)
The clinical course of alcoholic cirrhosis: development of comorbid diseases. A Danish nationwide cohort study (2016) (27)
Low free and total insulinlike growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatment (2002) (27)
Changes in bioactive IGF-I and IGF-binding protein-1 during an oral glucose tolerance test in patients with liver cirrhosis. (2006) (27)
Hormonal and neural blockade prevents the postoperative increase in amino acid clearance and urea synthesis. (1992) (26)
Branched-chain amino acids for people with hepatic encephalopathy. (2015) (26)
Socioeconomic status and survival of cirrhosis patients: A Danish nationwide cohort study (2009) (26)
Synthesis of acute phase proteins in rats with cirrhosis exposed to lipopolysaccharide (2006) (26)
Minimal hepatic encephalopathy characterized by parallel use of the continuous reaction time and portosystemic encephalopathy tests (2015) (25)
Family occurrence of autoimmune hepatitis: A Danish nationwide registry-based cohort study. (2018) (25)
Effect of lipopolysaccharide on in vivo and genetic regulation of rat urea synthesis (2005) (25)
GH decreases hepatic amino acid degradation after small bowel resection in rats without enhancing bowel adaptation. (2000) (25)
Low free and total insulinlike growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatment. (2002) (25)
Quality of life measures predict mortality in patients with cirrhosis and severe ascites (2018) (24)
Definition and assessment of low-grade hepatic encephalopathy (2006) (24)
Presence and consequence of tooth periapical radiolucency in patients with cirrhosis (2016) (24)
Vitamin B12 and its binding proteins in hepatocellular carcinoma and chronic liver diseases (2014) (24)
Role of branched chain amino acids in cerebral ammonia homeostasis related to hepatic encephalopathy (2013) (24)
Hospital admission for non-fatal poisoning with weak analgesics and risk for subsequent suicide: a population study (2009) (24)
Vitamin B-12 and folate function in chronic alcoholic men with peripheral neuropathy and encephalopathy. (1989) (23)
Non-alcoholic fatty liver disease causes dissociated changes in metabolic liver functions. (2019) (23)
Postoperative mortality in patients with liver cirrhosis undergoing transurethral resection of the prostate: a Danish nationwide cohort study (2001) (23)
Dose-dependent stimulation of insulin-like growth factor-binding protein-1 by lanreotide, a somatostatin analog. (1994) (22)
Increased hepatic urea synthesis in patients with active inflammatory bowel disease. (1996) (22)
The Circulating IGF System in Hepatocellular Carcinoma: The Impact of Liver Status and Treatment. (2015) (22)
Muscle metabolism and whole blood amino acid profile in patients with liver disease (2015) (22)
Effects of growth hormone (GH) administration on functional hepatic nitrogen clearance: studies in normal subjects and GH-deficient patients. (1994) (22)
Treatment of Budd-Chiari syndrome with a focus on transjugular intrahepatic portosystemic shunt. (2013) (22)
Effects of glucose on hepatic conversion of aminonitrogen to urea in patients with cirrhosis: Relationship to glucagon (1994) (22)
Cytotoxic T lymphocytes and natural killer cells display impaired cytotoxic functions and reduced activation in patients with alcoholic hepatitis. (2015) (22)
Time trends in incidence and prognosis of primary liver cancer and liver metastases of unknown origin in a Danish region, 1985–2004 (2008) (21)
Appendicectomy and perioperative mortality in patients with liver cirrhosis (2000) (21)
Effects of budesonide and prednisolone on hepatic kinetics for urea synthesis. (2000) (21)
Time‐trends in incidence and prognosis of hepatocellular carcinoma in Denmark: A nationwide register‐based cohort study (2017) (21)
Mortality after open cholecystectomy in patients with cirrhosis of the liver: a population-based study in Denmark. (2001) (21)
Increased capacity of urea synthesis in streptozotocin diabetes in rats (1986) (21)
Periodontitis in patients with cirrhosis: a cross-sectional study (2018) (21)
Protein tolerance to standard and high protein meals in patients with liver cirrhosis (2017) (20)
Unique subgingival microbiota associated with periodontitis in cirrhosis patients (2018) (20)
FDG-PET Improves Management of Patients with Colorectal Liver Metastases Allocated for Local Treatment: A Consecutive Prospective Study (2007) (19)
[Pattern of alcohol consumption in the Danish population in 1979]. (1981) (19)
Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis (2016) (19)
Increased energy expenditure and glucose oxidation during acute nontraumatic skin pain in humans (2009) (19)
Insulin sensitivity and body composition in cirrhosis: changes after TIPS. (2010) (18)
Effect of dietary protein on the capacity of urea synthesis in rats. (1990) (18)
Effects of common chronic medical conditions on psychometric tests used to diagnose minimal hepatic encephalopathy (2016) (18)
The continuous reaction time test for minimal hepatic encephalopathy validated by a randomized controlled multi-modal intervention—A pilot study (2017) (18)
Oxidative metabolism of astrocytes is not reduced in hepatic encephalopathy: a PET study with [11C]acetate in humans (2014) (18)
Decreasing Mortality Among Danish Alcoholic Cirrhosis Patients: A Nationwide Cohort Study (2016) (17)
Effects of urodilatin on natriuresis in cirrhosis patients with sodium retention (2007) (17)
Exogenous hyperglucagonaemia in insulin controlled diabetic rats increases urea excretion and nitrogen loss from organs (1988) (17)
Circulating mannan‐binding lectin, M‐, L‐, H‐ficolin and collectin‐liver‐1 levels in patients with acute liver failure (2015) (17)
Ascites from patients with alcoholic liver cirrhosis contains higher IGF‐I bioactivity than serum (2010) (17)
Benzodiazepines and risk for hepatic encephalopathy in patients with cirrhosis and ascites (2018) (17)
The clinical course of alcoholic cirrhosis: effects of hepatic metabolic capacity, alcohol consumption, and hyponatremia – a historical cohort study (2012) (17)
Recombinant activated factor VII in an unselected series of cases with upper gastrointestinal bleeding. (2006) (17)
Number connection test and continuous reaction times in assessment of organic and metabolic encephalopathy: a comparative study. (2009) (17)
Effect of Glutamine Synthetase Inhibition on Brain and Interorgan Ammonia Metabolism in Bile Duct Ligated Rats (2014) (17)
Oral health in patients with liver cirrhosis (2015) (16)
Moderate hyperthyroidism reduces liver amino nitrogen conversion, muscle nitrogen contents and overall nitrogen balance in rats (1997) (16)
Serum sodium as a risk factor for hepatic encephalopathy in patients with cirrhosis and ascites (2019) (16)
Effects of long-term growth hormone (GH) and triiodothyronine (T3) administration on functional hepatic nitrogen clearance in normal man. (1996) (16)
Update on the Therapeutic Management of Hepatic Encephalopathy (2018) (16)
A rapid method for determination of hepatic amino nitrogen to urea nitrogen conversion ('the Functional Hepatic Nitrogen Clearance'). (1994) (16)
The effect of continuous vasopressin infusion on splanchnic blood flow, liver function, and portal and central venous pressures in patients with cirrhosis. (1984) (16)
Combined liver vein and spleen pulp pressure measurements in patients with portal or splenic vein thrombosis (2004) (16)
Interorgan metabolism of ornithine phenylacetate (OP)--a novel strategy for treatment of hyperammonemia. (2013) (16)
High burden of coronary atherosclerosis in patients with cirrhosis (2017) (16)
A pilot study of Golexanolone, a new GABA-A receptor modulating steroid antagonist, in patients with covert hepatic encephalopathy. (2021) (16)
The damage‐associated molecular pattern HMGB1 is elevated in human alcoholic hepatitis, but does not seem to be a primary driver of inflammation (2016) (15)
Anti-CD163-dexamethasone conjugate inhibits the acute phase response to lipopolysaccharide in rats. (2016) (15)
Acute non-traumatic pain increases the hepatic amino- to urea-N conversion in normal man. (1999) (15)
The IGF system after insertion of a transjugular intrahepatic porto-systemic shunt in patients with liver cirrhosis. (2009) (15)
Extrahepatic autoimmune diseases in patients with autoimmune hepatitis and their relatives: A Danish nationwide cohort study (2018) (15)
Decreased muscle strength and contents of Mg and Na,K‐pumps in chronic alcoholics occur independently of liver cirrhosis (2003) (15)
No oxygen delivery limitation in hepatic encephalopathy (2010) (15)
Elimination of infused branched-chain amino-acids from plasma of patients with non-obese type 2 diabetes mellitus. (1991) (14)
Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis. (2020) (14)
Somatostatin-stimulated insulin-like growth factor binding protein-1 release is abolished by hyperinsulinemia. (1994) (14)
Hepatic encephalopathy (2022) (14)
Hepatic amino nitrogen conversion and organ N-contents in hypothyroidism, with thyroxine replacement, and in hyperthyroid rats. (1997) (14)
Transjugular intrahepatic portosystemic shunt does not alter cerebral blood flow. (2011) (14)
A comparative study of scientific evaluation of abstracts submitted to the 1995 European Association for the Study of the Liver Copenhagen meeting. (1998) (14)
Unexplained cholestasis in adults and adolescents: diagnostic benefit of genetic examination (2018) (14)
Contradictory effects of uncomplicated versus complicated abdominal surgery on the hepatic capacity for urea synthesis in rats. (1990) (14)
Intravenous and oral copper kinetics, biodistribution and dosimetry in healthy humans studied by [64Cu]copper PET/CT (2020) (13)
Magnesium supplementation and muscle function in patients with alcoholic liver disease: A randomized, placebo-controlled trial (2005) (13)
Changes in adipokines after transjugular intrahepatic porto-systemic shunt indicate an anabolic shift in metabolism. (2012) (13)
Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites (2019) (13)
Elective cholecystectomy increases plasma amino-acid clearance and hepatic capacity for urea synthesis for one week. (1991) (12)
Quantitative liver function and morphology after paracetamol administration to rats (1981) (12)
Insulin sensitivity in alcoholic cirrhosis. (1983) (12)
The in vivo effect of interleukin‐1β on urea synthesis is mediated by glucocorticoids in rats (1994) (12)
Alcohol acutely down-regulates urea synthesis in normal men. (2004) (12)
Post‐discharge Brief Intervention Increases the Frequency of Alcohol Abstinence—A Randomized Trial (2010) (12)
Urea synthesis in patients with chronic pancreatitis: relation to glucagon secretion and dietary protein intake. (2001) (12)
Tumor necrosis factor-α acutely up-regulates urea synthesis in vivo in rats – a hepatic component of inflammatory catabolism? (2010) (11)
Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis. (2016) (11)
The galactose elimination capacity as a quantitative measure of liver function in acute carbon tetrachloride intoxication of rats (1978) (11)
Effects of xylitol versus glucose on urea synthesis and alanine metabolism in rats. (1989) (11)
Publisher Correction: Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus (2017) (11)
Effects of epinephrine on urea synthesis in vivo in rats. (2008) (11)
Waist circumference and body mass index as predictors of elevated alanine transaminase in Danes aged 30 to 50 years. (1999) (11)
Non‐alcoholic steatohepatitis weakens the acute phase response to endotoxin in rats (2014) (11)
The association between admission for poisoning with paracetamol or other weak analgesics and subsequent admission for psychiatric disorder: a Danish nationwide case–control study (2005) (11)
Renal effects of a urodilatin infusion in patients with liver cirrhosis, with and without ascites. (1998) (11)
[Liver damage after paracetamol]. (1977) (11)
Cirrhosis and endotoxin decrease urea synthesis in rats (2007) (11)
Improvement of hyponatremia in cirrhosis is associated with improved complex information processing (2019) (10)
Fetal growth and adverse birth outcomes in women receiving prescriptions for acetaminophen during pregnancy. EuroMap Study Group. (1999) (10)
Familial Occurrence of Microscopic Colitis: an Opportunity to Study the Relationship between Microscopic Colitis and Coeliac Disease? (2002) (10)
Blood culture-positive infections in patients with alcoholic hepatitis (2014) (10)
Budd‐Chiari and inferior caval vein syndromes due to membranous obstruction of the liver veins: successful treatment with angioplasty and transcaval transjugular intrahepatic porto‐systemic shunt (2004) (10)
Effect of glucagon immunoneutralization on the increase in urea synthesis after hysterectomy in rats (1993) (10)
Acute effects of moderate dehydration on the hepatic conversion of amino nitrogen into urea nitrogen in healthy men. (2001) (10)
Glutamate Dehydrogenase Is Important for Ammonia Fixation and Amino Acid Homeostasis in Brain During Hyperammonemia (2021) (10)
Risk and Outcome of Venous and Arterial Thrombosis in Patients With Cirrhosis: A Danish Nation‐wide Cohort Study (2021) (10)
Severe periodontitis and higher cirrhosis mortality (2018) (10)
Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial (2019) (10)
Thirty-day postoperative mortality after hysterectomy in women with liver cirrhosis: a Danish population-based cohort study. (2002) (10)
Mortality and causes of death in patients with "lupoid hepatitis." A long-term follow-up study in Denmark. (2002) (10)
[Alcohol drinking patterns of the Danes 1979-1992]. (1998) (10)
MELD remains the best predictor of mortality in outpatients with cirrhosis and severe ascites (2020) (9)
[Primary sclerosing cholangitis with itching treated during pregnancy with ursodeoxycholic acid]. (1997) (9)
Hepatic amino- to urea-N clearance and forearm amino-N exchange during hypoglycemic and euglycemic hyperinsulinemia in normal man. (1999) (9)
Discharge diagnoses of liver diseases in Nuuk Greenland compared to a Danish county hospital (2006) (9)
Thirty‐day case fatality after nephrectomy in patients with liver cirrhosisA Danish population‐based cohort study (2003) (9)
Isolated congenital hepatic fibrosis associated with TMEM67 mutations: report of a new genotype–phenotype relationship (2017) (9)
Un‐precipitated acute kidney injury is uncommon among stable patients with cirrhosis and ascites (2018) (9)
Progressive resistance training prevents loss of muscle mass and strength in bile duct‐ligated rats (2018) (9)
Growth hormone and insulin-like growth factor-I counteracts established steroid catabolism in rats by effects on hepatic amino-N degradation. (2001) (8)
Kinetics of urea synthesis and alanine uptake by perfused rat livers. (2008) (8)
High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study (2018) (8)
Acute pain induces insulin resistance (2000) (8)
Low Interleukin-22 Binding Protein Is Associated With High Mortality in Alcoholic Hepatitis and Modulates Interleukin-22 Receptor Expression (2020) (8)
Reduced sCD36 following weight loss corresponds to improved insulin sensitivity, dyslipidemia and liver fat in obese children (2016) (8)
Regulation of urea synthesis during the acute-phase response in rats. (2013) (8)
Effects of insulin‐like growth factor‐I administration on in vivo regulation of urea synthesis in normal subjects and patients with cirrhosis (2011) (8)
Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients with cirrhosis (2019) (8)
Indomethacin prevents the increase in urea synthesis capacity and the weight loss after hysterectomy in rats. (1990) (8)
O073 : Non-selective beta-blockers and mortality in cirrhosis patients with or without refractory ascites: Post hoc analysis of three large RCT’s with 1198 patients (2015) (8)
Xylitol normalizes the accelerated hepatic capacity for conversion of amino nitrogen to urea nitrogen in diabetic rats. (1993) (8)
Relation between liver function and hepatocyte ultrastructure in a case of paracetamol intoxication. (1979) (8)
[Attitude of the population to organ transplantation]. (1994) (8)
Cerebral water content mapping in cirrhosis patients with and without manifest HE (2019) (8)
Hepatic microcirculation assessed by positron emission tomography of first‐pass ammonia metabolism in porcine liver (2005) (8)
Postoperative Hepatic Catabolic Stress Response in Patients with Cirrhosis and Chronic Hepatitis (2000) (8)
Increased Cancer Risk in Autoimmune Hepatitis: A Danish Nationwide Cohort Study (2021) (8)
Kinetics of galactose uptake by perfused rat livers: applicability of a family of models. (1983) (7)
Epilepsy as a risk factor for hepatic encephalopathy in patients with cirrhosis: a cohort study (2016) (7)
Effect of Branched Chain Amino Acids on the Outcome of Hepatic Encephalopathy (1984) (7)
Overt Hepatic Encephalopathy Experienced by Individuals With Cirrhosis: A Qualitative Interview Study (2017) (7)
Propranolol treatment of portal hypertension in cirrhosis patients is better the higher the untreated pressure: a single-centre prospective experience (2013) (7)
AASLD PRACTICE GUIDELINE Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver (2014) (7)
Cirrhosis is a risk factor for total hip arthroplasty for avascular necrosis (2016) (7)
The pathophysiology of Wilson’s disease visualized: A human 64Cu PET study (2021) (7)
Acute in vivo effects of low ethanol concentration on the capacity of urea synthesis in rats. (1991) (7)
IL-6 has no acute effect on the regulation of urea synthesis in vivo in rats (2011) (7)
Prednisolone but Not Infliximab Aggravates the Upregulated Hepatic Nitrogen Elimination in Patients with Active Inflammatory Bowel Disease (2014) (7)
Blockade of glucocorticoid receptors prevents the increase in urea synthesis after hysterectomy in rats (1991) (7)
Control of non-insulin-dependent diabetes mellitus partially normalizes the increase in hepatic efficacy for urea synthesis. (1994) (7)
No Effect in Alcoholic Hepatitis of Gut-Selective, Broad-Spectrum Antibiotics on Bacterial Translocation or Hepatic and Systemic Inflammation (2021) (7)
No effect of bicarbonate-induced alkalosis on urea synthesis in normal man. (1990) (7)
β-Blockers Improve Presinusoidal Portal Hypertension (2018) (7)
Time course of compromised urea synthesis in patients with alcoholic hepatitis (2018) (7)
Non‐alcoholic steatohepatitis, but not simple steatosis, disturbs the functional homogeneity of the liver – a human galactose positron emission tomography study (2019) (7)
The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease (2020) (6)
Urinary aquaporin-2 excretion before and after transjugular intrahepatic portosystemic shunt insertion for refractory ascites (2015) (6)
Enrichment of Genetic Variants in the Glucocorticoid Receptor Signalling Pathway in Autoimmune Hepatitis with Failure of Standard Treatment (2017) (6)
Diagnostic procedures in the evaluation of hepatic diseases. Functional evaluation of the hepatocyte. (1983) (6)
Resistance training improves muscle size and muscle strength in liver cirrhosis – a randomized controlled trial (2018) (6)
Glucose regulation of urea synthesis: relation to glucagon (1992) (6)
The influence of lithium on carbohydrate and lipid metabolism in the perfused rat liver. (2009) (6)
Galactose elimination kinetics in perfused rat liver after two thirds hepatectomy. (1984) (6)
L-ornithine L-aspartate for hepatic encephalopathy: a systematic review with meta-analyses of randomised controlled trials (2017) (6)
Where are we going? Translational research in hepatic encephalopathy (2016) (6)
Age-dependency of galactose elimination capacity in healthy children and children with chronic liver disease (2011) (6)
Decrease in ureagenesis by partial hepatectomy does not influence acid-base balance. (1989) (6)
Validation of a Simple Quality‐of‐Life Score for Identification of Minimal and Prediction of Overt Hepatic Encephalopathy (2020) (6)
Effects of lipopolysaccharide endotoxin on the insulin-like growth factor I system in rats with cirrhosis. (2008) (6)
Opposite effects of sleep deprivation on the continuous reaction times in patients with liver cirrhosis and normal persons (2014) (6)
Opposite effects on regulation of urea synthesis by early and late uraemia in rats. (2007) (6)
Liver cirrhosis is risk factor for pyogenic liver abscesses (2001) (6)
Cognitive impairment after liver transplantation: residual hepatic encephalopathy or posttransplant encephalopathy? (2019) (6)
Terlipressin for variceal bleeding induces large plasma sodium fluctuations in patients without cirrhosis (2018) (5)
Kinetics of hepatic alanine uptake and urea synthesis in pigs. (1988) (5)
Alanine Aminotransferase and 20-Year Risk of Major Chronic Diseases and Death in a Healthy Cohort Aged 30 to 49 Years (2020) (5)
Diagnosing covert hepatic encephalopathy (2015) (5)
Helicobacter pylori infection is not associated with rheumatoid arthritis (2018) (5)
Changes in liver-derived enzymes and self-reported alcohol consumption. A 1-year follow-up study in Denmark. (1999) (5)
Long‐term prognosis for transplant‐free survivors of paracetamol‐induced acute liver failure (2010) (5)
P1007 SOLUBLE CD163, A MACROPHAGE ACTIVATION MARKER, IS INDEPENDENTLY ASSOCIATED WITH FIBROSIS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS B AND C (2014) (5)
Soluble CD163 (sCD163): Biomarker of Kupffer Cell Activation in Liver Disease (2017) (5)
Decreased monocyte shedding of the migration inhibitor soluble CD18 in alcoholic hepatitis (2018) (5)
Risk Factors for Hepatic Hydrothorax in Cirrhosis Patients with Ascites – A Clinical Cohort Study (2021) (5)
Clinical Epidemiology (1997) (5)
Branched-chain amino acids for people with hepatic encephalopathy. (2015) (5)
Alcoholic Cirrhosis Increases Risk for Autoimmune Diseases: A Nationwide Registry-Based Cohort Study. (2015) (5)
Urea Synthesis in Humans — Preconditions of Quantitation and Relation to Liver Function (1984) (4)
Changes in the drinking pattern in Denmark from 1979 to 1992 | Danskernes alkoholforbrug 1979-1992 (1998) (4)
Impaired hepatic counterregulatory response to insulin-induced hypoglycemia in hepatic denervated pigs (2015) (4)
Effects of hysterectomy and semi-starvation on amino-acid gradients across liver, muscle and gut in rats. (1990) (4)
P0138 : The effect of treatment for hepatic encephalopathy with nonabsorbable disaccharides on morbidity and mortality in patients with cirrhosis: Systematic review and meta-analyses (2015) (4)
Activation and Functional Priming of Blood Neutrophils in Non-Alcoholic Fatty Liver Disease Increases in Non-Alcoholic Steatohepatitis (2021) (4)
Muscle GLUT4 in cirrhosis. (2007) (4)
Potassium deficiency decreases the capacity for urea synthesis and markedly increases ammonia in rats. (2021) (4)
Acetaminophen Use During Pregnancy: Effects on Risk for Congenital Abnormalities (2008) (4)
Effect of surgical stress and stress hormones' on urea synthesis in perfused rat livers (1993) (4)
Effects of laparotomy vs pneumoperitoneum on the hepatic catabolic stress response in ambulatory and stationary settings in pigs (1999) (4)
Low cerebral energy metabolism in hepatic encephalopathy reflects low neuronal energy demand. Role of ammonia-induced increased GABAergic tone. (2022) (4)
The impact of oral diseases in cirrhosis on complications and mortality (2021) (3)
Growth hormone and growth hormone secretagogue effects on nitrogen balance and urea synthesis in steroid treated rats. (2009) (3)
[Therapy of continuously bleeding oesophageal varices by self expanding metal stents]. (2007) (3)
[Liver biopsy in liver patients with coagulopathy]. (2008) (3)
Functional status of the liver during chronic renal failure: an experimental study in the rabbit. (2008) (3)
[Nonalcoholic steatohepatitis--a "new" hepatic disease]. (2003) (3)
HEP-12-0633 . R 3-Marked The Nutritional Management of Hepatic Encephalopathy in Patients with Cirrhosis : ISHEN Consensus (2013) (3)
Diabetes does not increase infection risk or mortality following an infection in patients with cirrhosis and ascites (2019) (3)
Physical exercise for people with cirrhosis (2017) (3)
Reply: To PMID 24623375. (2015) (3)
Renal effects of NO‐inhibition in patients with cirrhosis vs. healthy controls: a randomized placebo‐controlled crossover study (2014) (3)
L-ornithine L-aspartate for people with cirrhosis and hepatic encephalopathy (2016) (3)
[Cirrhosis of the liver]. (2014) (3)
Effect of fructose on the capacity of urea-N synthesis in rats. (1994) (3)
Effects of implementation of a national fast track clinical pathway for hepatocellular carcinoma in Western Denmark. (2019) (3)
Soluble membrane attack complex in ascites in patients with liver cirrhosis without infections. (2010) (3)
Glucagon receptor signaling is not required for L-carbamoyl glutamate and L-citrulline induced ureagenesis in mice. (2020) (3)
Psychometric methods for diagnosing and monitoring minimal hepatic encephalopathy —current validation level and practical use (2022) (3)
Lower muscle endurance in patients with alcoholic liver disease (2012) (3)
Unchanged capacity of urea synthesis during acute phase response in rats (2011) (3)
Nervous system damage and nutritional factors in chronic alcoholics (1989) (3)
Increased hepatic capacity of urea synthesis in acute and chronic uraemia in rats. (1991) (3)
[Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of complications of portal hypertension in patients with liver cirrhosis]. (2003) (3)
A "mini epidemic" of hepatitis A after eating Russian caviar. (1994) (3)
Non-alcoholic Fatty Liver Disease: Also a Disease of the Brain? A Systematic Review of the Preclinical Evidence. (2022) (3)
Severe periodontitis predicts higher cirrhosis mortality (2017) (2)
No net splanchnic release of glutathione in man during N-acetylcysteine infusion. (1993) (2)
A positive Helicobacter pylori test is associated with low spondylarthritis incidence in a Danish historical cohort study (2019) (2)
573 HEPATIC ENCEPHALOPATHY IS ASSOCIATED WITH IMPAIRED BRAIN OXYGEN METABOLISM AND BLOOD FLOW, NOT INCREASED AMMONIA UPTAKE (2012) (2)
Helicobacter pylori infection is associated with reduced prevalence of colonic diverticular disease (2017) (2)
Oral health and liver disease (2019) (2)
Impaired fibrinolysis without hypercoagulability characterises patients with non-alcoholic fatty liver disease. (2022) (2)
Effects of adrenalectomy on urea synthesis in rats. (1989) (2)
Risk for Hepatocellular Carcinoma in Patients With Alcoholic Cirrhosis (2012) (2)
Long‐Term Ethanol Exposure Decreases the Endotoxin‐Induced Hepatic Acute Phase Response in Rats (2017) (2)
Time‐dependent incidence and risk for myocardial infarction in patients with alcoholic cirrhosis (2020) (2)
[Budd-Chiari syndrome. Diagnosis and treatment]. (2002) (2)
Medical interventions for prevention and treatment of hepatic encephalopathy in adults with cirrhosis: a network meta-analysis (2018) (2)
Editorial: severe outcomes are rare in pregnancy in autoimmune hepatitis—Authors' reply (2018) (2)
Adipose tissue insulin resistance is associated with macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease (2016) (2)
Effects of acute carbon tetrachloride intoxication on kinetics of galactose elimination by perfused rat livers. (1983) (2)
Effect of dietary protein depletion on the galactose elimination capacity in intact rats. (1976) (2)
Alcohol increases glucagon secretion in normal man. (2004) (2)
[Prognosis and treatment of non-alcoholic fatty liver disease and steatohepatitis]. (2012) (2)
The effect of interleukin-1 on urea synthesis depends on glucocorticoids (1992) (2)
A rapid method for determination of the hepatic amino-N to urea-N conversion (the functional hepatic nitrogen clearance) (1991) (2)
Cognitive impairment in stable Wilson disease across phenotype (2021) (2)
Somatostatin prevents the postoperative increases in plasma amino acid clearance and urea synthesis after elective cholecystectomy. (1995) (2)
MHE Testing in Real World Scenario. (2018) (2)
QT interval corrected for heart rate is not associated with mortality in patients with cirrhosis and ascites (2019) (1)
THU-324-Non-alcoholic fatty liver disease causes dissociated changes in metabolic liver functions (2019) (1)
Early normalization of reduced urea synthesis capacity after direct-acting antiviral therapy in hepatitis C cirrhosis. (2020) (1)
LP21 : The macrophage activation markers soluble CD206 And CD163 predict mortality in patients with liver cirrhosis and acute-on-chronic liver failure (ACLF) (2015) (1)
194 INSULIN SENSITIVITY AND BODY COMPOSITION IN CIRRHOSIS: CHANGES AFTER TIPS (2009) (1)
215 Galactose elimination capacity and prognosis of patients with liver cirrhosis — A Danish registry-based cohort study with complete long-term follow-up (2004) (1)
The hepatic nitrogen metabolism in rats with intraperitoneal sepsis (1992) (1)
Does ammonia really disrupt brain oxygen homeostasis? (2022) (1)
[Increased urea synthesis in patients with active inflammatory bowel disease]. (1997) (1)
[Liver cirrhosis and bacterial infections]. (2005) (1)
Autoimmune hepatitis and cancer risk – a Danish nationwide cohort study (2020) (1)
Poster presentationBlockade of corticosteroid receptors prevents the increase in hepatic amino acid conversion after hysterectomy in rats (1990) (1)
[Pharmacologic treatment or endoscopic sclerotherapy as primary intervention for bleeding varices in cirrhotic patients]. (2003) (1)
[Surgical risk for patients with liver disease]. (2006) (1)
Effect of lanreotide, a somatostatin analogue, on urea synthesis in normal man. (1994) (1)
Liver function during chronic renal failure in rabbits (1984) (1)
Early loss of T lymphocyte 4-1BB receptor expression is associated with higher short-term mortality in alcoholic hepatitis. (2021) (1)
Branched Chain Amino Acids and Blood Ammonia (2015) (1)
Dose-Dependent Inhibition by Salicylic Acid of Alanine Uptake and Urea Synthesis in Perfused Rat Livers (1984) (1)
[Pseudosarcomatous fibromyxoid tumor in the spermatic cord]. (1996) (1)
Quality of Life Assessment can be Used to Diagnose Covert Hepatic Encephalopathy (2016) (1)
Normalisation of insulin‐like growth factor‐I does not improve insulin action in cirrhosis (2011) (1)
Postoperative hepatic catabolism of amino-N to urea-N depends on both the trauma itself and on the hormonal stress response (1991) (1)
A mathematical model to describe urea appearance in response to alanine. Validation in subjects with and without glucose superinfusion (1993) (1)
99 RISK OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH LIVER DISEASE: A NATIONWIDE POPULATION- BASED CASE-CONTROL STUDY (2009) (1)
Growth hormone secretagogue ipamorelin reduces the hepatic catabolic stress response during steroid treatment (1998) (1)
Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus (2017) (1)
Extrahepatic autoimmune diseases in patients with autoimmune hepatitis and their relatives: a Danish nationwide family cohort study (2018) (1)
P300 ALCOHOLIC LIVER DISEASE IN DENMARK 2006–2011: A POPULATION-BASED DESCRIPTIVE STUDY (2014) (1)
The long-term prognosis of alcoholic hepatitis is poor and independent of disease severity for patients surviving an acute episode. (2018) (1)
Editorial: measuring inflammatory and fibrotic components of portal hypertension – a non‐invasive hepatic venous pressure gradient? Authors’ reply (2016) (1)
Hepatic amino acid conversion and urea synthesis (1990) (1)
[TIPS--transjugular intrahepatic portosystemic shunt. Experiences from a recently started center]. (2003) (1)
P1055 : The macrophage activation marker soluble CD163 is independently associated with the severity of NAFLD in morbid obesity and reduced by bariatric surgery (2015) (1)
Time-Trends in Incidence and Survival of Hepatocellular Carcinoma in Denmark: A Nationwide Register-Based Cohort Study (2016) (1)
Lower Incidence of Hepatobiliary Cancer in Helicobacter pylori-Infected Persons: A Cohort Study of 53.633 Persons (2021) (1)
Importance of hyperglycaemia for suppression of urea synthesis by glucose in man (1993) (1)
Treatment of Hepatic Encephalopathy with Branched Chain Amino Acid Enriched Solutions. A Review of Randomized Controlled Trials (1984) (1)
P.43 Growth hormone normalizes the increased hepatic amino-N into urea-N conversion in steroid treated rats and decreases hepatic mRNA levels of urea cycle enzymes (1996) (1)
1000 THE CLINICAL COURSE OF ALCOHOLIC LIVER CIRRHOSIS: A DANISH POPULATION-BASED STUDY (2009) (1)
Impact and Diagnosis of Minimal or Grade 1 Hepatic Encephalopathy (2018) (1)
No Increased Risk for Primary Osteoarthritis in Liver Cirrhosis – A Danish Nationwide Cohort Study (2016) (1)
Reply: To PMID 22886493. (2013) (1)
Hepatic encephalopathy: an enigma from patient to enzyme and back (2013) (1)
Interleukin-22 binding protein in alcoholic hepatitis (2018) (1)
Kinetics of Urea Synthesis during Infusion of Valine in Intact Rats (1984) (1)
P0113 : Regional cerebral water content in hepatic encephalopathy measured by MRI (2015) (1)
[Value of FDG-PET scan before treatment of liver metastases from colorectal cancer--a secondary publication]. (2008) (0)
[Rearrangements in research fellow appointments to the University Hospital in Copenhagen: the first 100 projects]. (1988) (0)
„Increased long-term risk for auto-immune diseases in liver cirrhosis: a nation-wide population-based cohort study (2012) (0)
116 DYSFUNCTIONAL NK, NKT AND NK-LIKE CD8+ T CELLS IN ALCOHOLIC HEPATITIS (2013) (0)
CEG_A_329424 441..449 (2021) (0)
Hepatic encephalopathy. (2022) (0)
O.80 Opposite effects of hyperinsulinaemic eu- and hypoglycaemia on hepatic regulation of amino-to urea-N conversion (1996) (0)
Studies to develop a glucagon sensitivity test in humans: The GLUSENTIC study protocol (2022) (0)
Guillain-Barrés syndrom efter influenzavaccination (2009) (0)
216-LB: Development and Evaluation of a Glucagon Sensitivity Test in Humans (2021) (0)
Clearance and production of ammonia quantified in humans by constant ammonia infusion - the effects of cirrhosis and ammonia targeting treatments. (2023) (0)
MELD remains the best predictor of mortality in outpatients with cirrhosis, severe ascites, and MELD score ≤ 18 (2020) (0)
569 Magnesium supplementation in alcoholic liver disease — A randomised trial (2004) (0)
P1134 : The leukocyte migration inhibitor soluble CD18 increases with severity of human alcoholic hepatitis (2015) (0)
721 INCIDENCE OF HEPATOCELLULAR CARCINOMA IN ALCOHOLIC CIRRHOSIS (2012) (0)
Case report: Huppke–Brendel syndrome in an adult, mistaken for and treated as Wilson disease for 25 years (2022) (0)
THU-400-Alanine-aminotransferase and 20-year risk of liver disease, cancer, ischemic heart disease, and diabetes in a Danish general population sample aged 30-49 years (2019) (0)
Reduced skeletal muscle concentrations of Mg and NA, K-pumps inchronic alcoholics (2000) (0)
P.132 Potassium deficiency induces N-loss anddecreases liver function (1998) (0)
[Hepatic pruritus]. (2006) (0)
Response to Chang et al. (2022) (0)
77 Risk of hospitalization for psychiatric disorder after hospitalization for paracetamol or other drug poisoning — A Danish nation-wide registry-based case-control study (2004) (0)
532 Heterogeneity of intrahepatic arterio-portal blood mixing studied by N-ammonia PET of intact pig liver (2003) (0)
Letter: autoimmune hepatitis—drug‐induced liver injury must always be excluded. Authors’ reply (2017) (0)
Proton Pump Inhibitors Increase the Risk for Infections in Cirrhosis Patients with Ascite (2016) (0)
P1070 : The marker of macrophage activation soluble CD163 is associated with liver histology in children with non-alcoholic fatty liver disease (2015) (0)
752 EFFECT OF TIPS ON SOLUBLE CD163 IN PATIENTS WITH LIVER CIRRHOSIS (2009) (0)
The galactose elimination capacity test to monitor liver disease course in patients with Wilson’s disease (2022) (0)
1342 CHANGE IN SOLUBLE CD163, A MARKER OF ACTIVATED MACROPHAGES, IS ASSOCIATED WITH IMPROVEMENT IN LIVER ENZYMES AND METABOLIC PROFILE IN OBESE CHILDREN DURING LIFESTYLE INTERVENTION (2013) (0)
472 LONG-TERM PROGNOSIS FOR TRANSPLANT-FREE SURVIVORS OF PARACETAMOL-INDUCED ACUTE LIVER FAILURE (2009) (0)
MHE Testing in Real World Scenario — A Mini-Review (2018) (0)
627 LIVER CIRRHOSIS INCREASES LONG-TERM RISK FOR AUTOIMMUNITY: A NATIONWIDE POPULATION-BASED COHORT STUDY (2012) (0)
[Guillain-Barre syndrome after influenza vaccination]. (2009) (0)
The physical component of the SF-36 Quality of Life tool is an independent predictor of mortality in patients with severe ascites (2018) (0)
[Treatment of bleeding esophageal varices. A 20-year old research-based successful history--how does it continue?]. (2007) (0)
Den akutte medicinske patient (2015) (0)
Publisher Correction: Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus (2017) (0)
Role of branched chain amino acids in cerebral ammonia homeostasis related to hepatic encephalopathy (2013) (0)
Increased hepatic degradation of amino acids (AA) during hemodialysis (HD) in pigs is followed by AA efflux from skeletal muscles (1998) (0)
Oral Branch Chain Amino Acids and Encephalopathy (2015) (0)
Hepatic macrophage activation is associated with adipose tissue insulin resistance in non-diabetic patients with Non-Alcoholic Fatty Liver Disease (2016) (0)
Pain is a hepatic catabolic stimulus in normal man (1998) (0)
Effects of changes in blood amino acid availability on muscle and liver amino-N exchange (2002) (0)
689 A registry-based study of the incidence of liver disease in Denmark, 1996–2001 (2006) (0)
Branched chain amino acids in clinical nutrition Vol 2: Oral Branch Chain Amino Acids and Encephalopathy (2015) (0)
Subject Index Vol. 33, Suppl. 2, 2015 (2015) (0)
[Treatment of chronic hepatitis C--ribavirin plus interferon versus interferon. An analysis of a systematic Cochrane review]. (2006) (0)
[TIPS--a therapeutic progress in portal hypertension]. (1998) (0)
Periodontitis in patients with cirrhosis: a cross-sectional study (2018) (0)
1371 IL-22 PRODUCING T CELLS ARE ASSOCIATED WITH A FAVOURABLE DISEASE COURSE IN ALCOHOLIC HEPATITIS (2012) (0)
Cerebral effects of ammonia in liver disease: current hypotheses (2014) (0)
Development and validation of the Cirrhotic Ascites Severity model—A patient‐reported outcome‐based model to predict 1‐year mortality (2022) (0)
Oral health and the impact of oral diseases on the clinical course of cirrhosis (2020) (0)
Where are we going? Translational research in hepatic encephalopathy (2015) (0)
Codes for reactor computations (1961) (0)
48 A NATIONWIDE STUDY OF THE INCIDENCE AND MORTALITY RATE OF ALCOHOLIC HEPATITIS IN DENMARK, 1999–2008 (2010) (0)
H EPATIC ENCEPHALOPATHY : N OVEL INSIGHTS INTO CLASSIFICATION , PATHOPHYSIOLOGY AND THERAPY . (2020) (0)
Terlipressin for variceal bleeding induces severe plasma sodium disturbances in non-cirrhotic portal hypertension (2018) (0)
Contents, Vol. 19, 1979 (1979) (0)
THU-281-Single nucleotide polymorphisms associated with no interferon lambda 4 production are associated with reduced mortality in alcoholic hepatitis (2019) (0)
201 LONG-TERM EFFECT OF PROPRANOLOL ON PORTAL HYPERTENSION IN PATIENTS WITH CIRRHOSIS: A SINGLE CENTRE PROSPECTIVE EXPERIENCE (2013) (0)
Insulin-like growth factor-I improves glucose metabolism and hepatic amino acid-N conversion in patients with liver cirrhosis (2000) (0)
The Continuous Reaction Times Test for Minimal Hepatic Encephalopathy Validated by a Randomized Controlled Multi-modal Intervention (2017) (0)
Alcoholic cirrhosis is not a risk factor for acute myocardial infarction: a nationwide cohort study (2017) (0)
Insulin-like growth factor-I (IGF-I) alone and combined with growth hormone (GH) limits hepatic N-loss and improves musle N-exchange (2000) (0)
Reduced incidence of hepatobiliary cancers in helicobacter pylori infected persons in a population-based cohort study (2020) (0)
Opposite effects of sleep deprivation on the continuous reaction times in patients with liver cirrhosis and normal persons (2014) (0)
Reply (2013) (0)
The association between serum sodium and rate of hepatic encephalopathy in cirrhosis patients with ascites (2017) (0)
THU-325-Regional liver function investigated by galactose positron emission tomography is reduced in patients with non-alcoholic steatohepatitis (2019) (0)
Reply (2016) (0)
Table 1. Multiple Ordered Logistic Regression Analysis in Patients With HCV and HBV Infection (2015) (0)
sMAC in plasma and ascites from patients with liver cirrhosis (2008) (0)
An experimental pain model that combines acute severe pain with minimal tissue damage (1997) (0)
544 Liver Cirrhosis Increases Long-Term Risk for Autoimmunity: A Nationwide Population-Based Cohort Study (2012) (0)
[Treatment of portal hypertension with transjugular intrahepatic portosystemic shunt: guidelines for referring suitable patients]. (2007) (0)
252 TUMOR NECROSIS FACTOR-ALPHA ACUTELY UP-REGULATES UREA SYNTHESIS IN VIVO IN RATS – A HEPATIC ELEMENT OF INFLAMMATORY CATABOLISM (2009) (0)
FRI-265-Twelve weeks of effective resistance training did not change the gut microbiota in patients with cirrhosis (2019) (0)
Reply (2017) (0)
Experimental non-alcoholic fatty liver disease causes regional liver functional deficits as measured by the capacity for galactose metabolism while whole liver function is preserved (2022) (0)
No net splanchnic release of glutathione (1991) (0)
The acute phase response increases the ability of urea synthesis but decreases hepatic gene expression of the rate-limiting urea cycle enzyme (2002) (0)
271-OR: Hepatic Glucagon Resistance in Mice with Nonalcoholic Fatty Liver Disease (2022) (0)
O.54 Growth hormone and IGF-I counteract catabolismduring steroid treatment; partly by inhibiting steroid induced increase of in vivo ureagenesis and urea enzyme gene expression (1998) (0)
Correction: Experimental non-alcoholic fatty liver disease causes regional liver functional deficits as measured by the capacity for galactose metabolism while whole liver function is preserved (2023) (0)
[233] GALACTOSE ELIMINATION CAPACITY IS A PREDICTOR OF SURVIVAL TIME IN PATIENTS WITH CIRRHOSIS OF THE LIVER (2007) (0)
P299 TIME TRENDS IN SURVIVAL OF ALCOHOLIC LIVER DISEASE IN DENMARK: A POPULATION-BASED NATIONWIDE COHORT STUDY (2014) (0)
84l-Ornithine l-Aspartate for Hepatic Encephalopathy: A Systematic Review with Meta-Analyses of Randomised Controlled Trials (2017) (0)
Effect of spironolactone on skeletal muscle concentrations of Mg, K and Na, K-pumps in alcoholics with cirrhosis (2001) (0)
[Hepatic encephalopathy. The Danish Society of Hepatology]. (2007) (0)
Cirrhosis impairs the hepatic contribution to the nitrogen sparing effect of glucose (1991) (0)
Synthesis ofureaafter stimulation withaminoacids: relation toliver function (2017) (0)
BRIEF COMMUNICATION Transjugular Intrahepatic Portosystemic Shunt Does Not Alter Cerebral Blood Flow (2011) (0)
A novel cirrhotic ascites severity score predicts one-year mortality better than the classification into refractory or diuretic-responsive ascites (2022) (0)
Correction: Decreased monocyte shedding of the migration inhibitor soluble CD18 in alcoholic hepatitis (2018) (0)
Role of Ammonia in NAFLD: An Unusual Suspect (2023) (0)
Xylitol normalises the increased capacity of urea synthesis and improves the nitrogen balance in rats with experimental diabetes (1990) (0)
1343-P: The Acute Effects of Glucagon on Glucose Dynamics Are Not Impaired in Individuals with Nonalcoholic Fatty Liver Disease (2022) (0)
Organ distinct importance of insulin and amino-N for tissue protein contents (1991) (0)
Reduced three-year risk of hospital admission and mortality after 12-weeks resistance training of cirrhosis patients - a follow-up of a randomized clinical trial. (2023) (0)
O.11 Xylitol reduces urea synthesis inpatients with cirrhosis (1996) (0)
Growth hormone decreases hepatic amino acid degradation after major surgery in rats (1998) (0)
Hypokalaemia - an active contributor to hepatic encephalopathy? (2022) (0)
Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis (2012) (0)
[Portosystemic shunts versus endoscopic therapy for esophageal varices after the first bleeding: does the Cochrane analysis give a complete answer?]. (2007) (0)
Disease-Related Variants in Genes Involved in Bile Formation and Transport Demonstrated in 12 of 22 Patients with “Unexplained Cholestasis” by the Use of a Novel Panel for Genetic Testing (2016) (0)
[203] IGF-1 SUPPLEMENTATION DOES NOT IMPROVE INSULIN ACTION IN CIRRHOSIS (2007) (0)
Effects of xylitol on urea synthesis in patients with cirrhosis of the liver. (1998) (0)
Bianchi, L., Gerok, W., Landmann, L., Sickinger, K. and Stalder, G. A. (eds.): Liver in metabolic diseases (Falk Symposium 35) (2008) (0)
Reply to 16-1559. (2016) (0)
753 THE GALACTOSE ELIMINATION CAPACITY AND MORTALITY IN 781 DANISH PATIENTS WITH NEWLY- DIAGNOSED LIVER CIRRHOSIS: A COHORT STUDY (2009) (0)
Enrichment of genetic variants in the glucocorticoid receptor signalling pathway in standard treatment failure autoimmune hepatitis (2017) (0)
P: 58 Prediction of Overt Hepatic Encephalopathy by the Continuous Reaction Time Method and the Portosystemic Encephalopathy Syndrome Test in Patients With Cirrhosis (2019) (0)
Substrate regulation of ketogenesis in the human liver (1987) (0)
Hepatic amino-N conversion in cirrhosis: effect of somatostatin and glucose (1993) (0)
Reply: (2010) (0)
Effect of oral zinc regimens on human hepatic copper content: a randomized intervention study (2022) (0)
Development of a glucagon sensitivity test in humans: Pilot data and the GLUSENTIC study protocol (2022) (0)
Deep hyperammonemic hepatic encephalopathy precipitated by fecal microbiota transplantation for fulminant Clostridioides difficile infection (2021) (0)
Metabolic response to acute pain (1997) (0)
[Positron-emission tomography of liver tumors]. (1999) (0)
P824 SOLUBLE CD163, A MACROPHAGE ACTIVATION MARKER, IS INDEPENDENTLY ASSOCIATED WITH STEATOHEPATITIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (2014) (0)
Syddansk Universitet Antibody-Directed Glucocorticoid Targeting to CD 163 in M 2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes (2017) (0)
Effects of growth hormone on steroid-induced increase in ability of urea synthesis and urea enzyme mRNA levels. (1998) (0)
[TIPS is a life-prolonging treatment of those cirrhosis patients with ascites who can not be treated medically or with paracentesis]. (2005) (0)
Effects of insulin-like growth factor-I on glucose metabolism and hepatic amino acid-N conversion in patients with liver cirrhosis (2001) (0)
Vitamin D deficiency is frequent in cirrhosis (2008) (0)
P: 72 Hyponatremia Correction in Cirrhosis May Increase the Speed of Complex Information Processing (2019) (0)
Reduced effect of glucose on hepatic amino-N to urea-N conversion in cirrhosis (1991) (0)
Effect of spontaneous bacterial peritonitis on mortality among patients with alcoholic cirrhosis and ascites (2017) (0)
Effects of Anaerobic Exercise in Muscle Strength and Muscle Mass Optimization in Bile Duct Ligated Rats (2017) (0)
O.58 Effects of growth hormone and insulin-likegrowth factor-I singly and in combination on in vivo capacity of urea synthesis, expression of urea cycle enzymes and organ N-contents in rats (1996) (0)
P1061 : The macrophage activation marker SCD163 and the apoptosis marker cytokeratin-18 are both predictors of disease severity in patients with non-alcoholic fatty liver disease (2015) (0)
The clinical course of alcoholic cirrhosis: effects of hepatic metabolic capacity, alcohol consumption, and hyponatremia – a historical cohort study (2012) (0)
Effects of surgical stress and semi-starvation on amino acid gradients across liver, gut, and muscle in rats (1990) (0)
Periodontitis in patients with cirrhosis (2018) (0)
Reply (2017) (0)
[Antibiotic prophylaxis in variceal bleeding to patients with liver cirrhosis? Yes!]. (2005) (0)
P: 40 Potassium Deficiency Compromises Urea Synthesis and Markedly Increases Ammonia in Rats (2019) (0)
Acute non-traumatic pain increases the hepatic conversion in normal man amino- to urea-N (1999) (0)
Branched-chain amino acids and muscle ammonia detoxification in cirrhosis (2013) (0)
Syddansk Universitet The continuous reaction time test for minimal hepatic encephalopathy validated by a randomized controlled multi-modal intervention A pilot study (2018) (0)
Acute Non-Traumatic Pain Increases Energy Expenditure and Leads to Accelerated Fat Oxidation: [2002][A-842] (2002) (0)
Efficacy of zinc on human hepatic copper uptake depending on zinc type and dose regimen quantified with 64-CuCl2 PET/CTscan (2020) (0)
In vivo human insulin release processes measured by intraportal sampling through transjugular intrahepatic portal-systemic shunt (TIPS) (2000) (0)
Cerebral water content mapping in cirrhosis patients with and without manifest HE (2019) (0)
[Alcohol consumption and liver enzymes in persons 30-50 years of age. Cross-sectional study from Ebeltoft]. (1997) (0)
P-69 Patients with liver cirrhosis have higher levels of bioactive IGF-I in ascites than in serum (2008) (0)
Thyroid Disease and Hepatocellular Carcinoma Survival: A Danish Nationwide Cohort Study (2021) (0)
Spontaneous bacterial peritonitis has no effect on the long-term prognosis of cirrhosis patients with ascites. (2022) (0)
P: 14 Non-alcoholic Fatty Liver Disease Alters Expression of Genes Governing Hepatic Nitrogen Conversion (2019) (0)
198 SOCIOECONOMIC STATUS AND MORTALITY AMONG CIRRHOSIS PATIENTS: A DANISH NATIONWIDE COHORT STUDY (2009) (0)
IGF-1, IGFBP-3 and insulin sensitivity during weight loss in children (2017) (0)
252 Detection of hepatocellular carcinoma by dynamic 13NH3- and 18FDG-PET scanning (2004) (0)
1301 ENDOTOXIN CAUSES HIGH MORTALITY AND REDUCED HEPATIC SYNTHESIS OF ACUTE PHASE PROTEINS IN RATS WITH EXPERIMENTAL NON-ALCOHOLIC FATTY LIVER DISEASE (2013) (0)
Vitamin D deficiency is frequent in liver cirrhosis (2008) (0)
P0172 : Proton pump inhibitors increase the risk for hepatic encephalopathy in cirrhosis (2015) (0)
1375 PROGNOSIS OF ALCOHOLIC PURE STEATOSIS AND STEATOHEPATITIS: A NATIONWIDE BIOPSY- AND REGISTRY-BASED STUDY (2012) (0)
Su2013 – Effects of Glepaglutide, a Novel Long-Acting Glucagon-Like Peptide-2 Analog, on Activation of Liver Macrophages and Gut Integrity in Patients with Short Bowel Syndrome (2019) (0)
SAT-029-Prediction of hepatic hydrothorax in cirrhosis patients with ascites (2019) (0)
Satavaptan treatment for ascites in patients with cirrhosis: a meta-analysis of effect on hepatic encephalopathy development (2013) (0)
P320 ALCOHOLIC HEPATITIS DECREASES THE CAPACITY FOR UREA SYNTHESIS (2014) (0)
Patients with Liver Cirrhosis Have Similar Prevalence, but Higher Burden of Coronary Artery Disease Compared to Patients Evaluated for Angina Pectoris (2016) (0)
Blockade of glucagon abolishes post-operative catabolism (1992) (0)
Acute in vivo effects of low and high doses of ethanol on hepatic nitrogen metabolism in normal man (2000) (0)
Reply (2015) (0)
Crosstalk between adipose tissue insulin resistance and liver macrophage activation in patients with Non-Alcoholic Fatty Liver Disease (2020) (0)
High protein diet increases hepatic efficacy for urea synthesis in control persons and in patients with cirrhosis (1990) (0)
288 COMORBIDITY AND SURVIVAL OF DANISH CIRRHOSIS PATIENTS - A NATIONWIDE POPULATION-BASED COHORT STUDY (2008) (0)
A simple patient-reported instrument can predict development of overt hepatic encephalopathy (2018) (0)
723 SOLUBLE CD163, A MARKER FOR MACROPHAGE ACTIVATION, IS NOT ASSOCIATED TO HCC, PER SE BUT PREDICTS DISEASE PROGRESSION (2012) (0)
Interferon lambda 4 genotype and pathway in alcoholic hepatitis (2021) (0)
[Epidemiology for alcohol-related liver disease]. (2021) (0)
[Fundamental errors in observed researches]. (1994) (0)
P0114 : Cirrhosis is associated with avascular necrosis, but not osteoarthritis - A Danish population-based study (2015) (0)
Hepatic encephalopathy: an enigma from patient to enzyme and back (2013) (0)
Subject Index, Vol. 19, 1979 (1979) (0)
P: 70 Quality of Life Assessment May Aid in the Diagnosis of Minimal Hepatic Encephalopathy and Prediction of Overt Hepatic Encephalopathy (2019) (0)
Cognitive impairment in stable Wilson disease across phenotype (2021) (0)
Alkoholisk hepatitis - epidemiologi, diagnostik og behandling (2013) (0)
SAT-056-Development of a novel prognostic model for cirrhotic patients with difficult-to-treat ascites and low MELD scores (2019) (0)
263 The incidence of primary liver cancer in Denmark: A 25-year population-based study (2006) (0)
Experimental non-alcoholic fatty liver disease causes regional liver functional deficits while total metabolic liver function is preserved (2022) (0)
HMER_A_144667 41..46 (2019) (0)
Tolerance : The Insulin Resistance Atherosclerosis Study Cross-Sectional and Longitudinal Changes of Glucose Effectiveness in Relation to Glucose (2011) (0)
Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence? (2012) (0)
[Danish clinical hepatoepidemiology. The Danish Society of Hepatology]. (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Hendrik Vilstrup?

Hendrik Vilstrup is affiliated with the following schools:

Aarhus University
Technical University of Denmark
University of Copenhagen

Hendrik Vilstrup's Academic­Influence.com Rankings

Hendrik Vilstrup's Degrees

Why Is Hendrik Vilstrup Influential?

Hendrik Vilstrup's Published Works

Published Works

What Schools Are Affiliated With Hendrik Vilstrup?

Hendrik Vilstrup's AcademicInfluence.com Rankings